IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

CUSIP: 4525EP101

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
131,806,674
Total 13F shares
2,138,466
Share change
+639,202
Total reported value
$20,744,048
Price per share
$9.70
Number of holders
14
Value change
+$6,193,891
Number of buys
6
Number of sells
9

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 4525EP101?
CUSIP 4525EP101 identifies IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Omega Fund Management, LLC
13F
Company
1%
1,371,494
$13,715,000 30 Sep 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.03%
42,029
$420,000 30 Sep 2019
13F
BlackRock Finance, Inc.
13F
Company
0.02%
25,186
$251,000 30 Sep 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.01%
11,937
$120,000 30 Sep 2019
13F
VANGUARD GROUP INC
13F
Company
0.01%
11,520
$116,000 30 Sep 2019
13F
Verition Fund Management LLC
13F
Company
0.01%
11,301
$114,000 30 Sep 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
10,526
$105,000 30 Sep 2019
13F
CREDIT AGRICOLE S A
13F
Individual
0.01%
9,700
$97,000 30 Sep 2019
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0%
1,728
$17,000 30 Sep 2019
13F
JPMORGAN CHASE & CO
13F
Company
0%
1,275
$13,000 30 Sep 2019
13F
Quantamental Technologies LLC
13F
Company
0%
999
$10,000 30 Sep 2019
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
610
$6,000 30 Sep 2019
13F
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC
13F
Company
0%
297
$3,000 30 Sep 2019
13F
Berman Capital Advisors, LLC
13F
Company
0%
206
$2,000 30 Sep 2019
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
192
$1,920 30 Sep 2019
13F
MEEDER ASSET MANAGEMENT INC
13F
Company
0%
145
$1,000 30 Sep 2019
13F
MORGAN STANLEY
13F
Company
0%
123
$1,000 30 Sep 2019
13F
CITIGROUP INC
13F
Company
0%
111
$1,000 30 Sep 2019
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0%
72
$1,000 30 Sep 2019
13F

Institutional Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q4 2019

As of 31 Dec 2019, IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,138,466 shares. The largest 10 holders included Omega Fund Management, LLC, Artal Group S.A., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Verition Fund Management LLC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
18
Q4 2019 holders
14
Holder diff
-4
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 Value $ Q4 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.